{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T06:03:01Z","timestamp":1703052181697},"reference-count":36,"publisher":"Japan Society for Clinical Immunology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2177\/jsci.40.124","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T22:15:07Z","timestamp":1497219307000},"page":"124-130","source":"Crossref","is-referenced-by-count":3,"title":["Neonatal lupus erythematosus"],"prefix":"10.2177","volume":"40","author":[{"given":"Naoto","family":"YOKOGAWA","sequence":"first","affiliation":[{"name":"Tokyo Metropolitan Tama Medical Center, Department of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"SUMITOMO","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Children's Medical Center, Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"MIURA","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Children's Medical Center, Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"SHIBUYA","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Children's Medical Center, Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"NAGAI","sequence":"additional","affiliation":[{"name":"Kobe University Graduate School of Medicine, Division of Dermatology, Department of Internal Related"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"GOTO","sequence":"additional","affiliation":[{"name":"National Center for Child Health and Development, The Japan Drug Information Institute in Pregnancy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"MURASHIMA","sequence":"additional","affiliation":[{"name":"National Center of Child health and Development, Division of Maternal Medicine, Department of Perinatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Mc, C.C., Schoch, E.P., Jr.: Possible discoid lupus erythematosus in newborn infant; report of a case with subsequent development of acute systemic lupus erythematosus in mother. <i>AMA archives of dermatology and syphilology<\/i>. <b>70<\/b>: 782-785, 1954."},{"key":"2","unstructured":"2) Scott, J.S., et al.: Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. <i>The New England journal of medicine<\/i>. <b>309<\/b>: 209-212, 1983."},{"key":"3","unstructured":"3) Cimaz, R., et al.: Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-Ro autoantibodies. <i>The Journal of pediatrics<\/i>. <b>142<\/b>: 678-683, 2003."},{"key":"4","unstructured":"4) Neiman, A.R., et al.: Cutaneous manifestations of neonatal lupus without heart block: Characteristics of mothers and children enrolled in a national registry. <i>The Journal of pediatrics<\/i>. <b>137<\/b>: 674-680, 2000."},{"key":"5","unstructured":"5) Miyagawa, S.: Neonatal lupus erythematosus: A review of the racial differences and similarities in clinical, serological and immunogenetic features of Japanese versus Caucasian patients. <i>The Journal of dermatology<\/i>. <b>32<\/b>: 514-522, 2005."},{"key":"6","unstructured":"6) Rivera, T.L., et al.: Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. <i>Annals of the rheumatic diseases<\/i>. <b>68<\/b>: 828-835, 2009."},{"key":"7","unstructured":"7) Izmirly, P.M., et al.: Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block. <i>Arthritis and rheumatism<\/i>. <b>62<\/b>: 1153-1157, 2010."},{"key":"8","unstructured":"8) Brito-Zeron, P., et al.: The clinical spectrum of autoimmune congenital heart block. <i>Nature reviews Rheumatology<\/i>. <b>11<\/b>: 301-312, 2015."},{"key":"9","unstructured":"9) \u300c\u81ea\u5df1\u6297\u4f53\u967d\u6027\u5973\u6027\u306e\u598a\u5a20\u7ba1\u7406\u6307\u91dd\u306e\u4f5c\u6210\u53ca\u3073\u65b0\u751f\u5150\u30eb\u30fc\u30d7\u30b9\u306e\u767a\u75c7\u30ea\u30b9\u30af\u306e\u8efd\u6e1b\u306b\u95a2\u3059\u308b\u7814\u7a76\u300d\u7814\u7a76\u73ed\uff1a\u6297SS-A\u6297\u4f53\u967d\u6027\u5973\u6027\u306e\u598a\u5a20\u306b\u95a2\u3059\u308b\u8a3a\u7642\u306e\u624b\u5f15\u304d\uff0c2013\u5e743\u6708\uff0e"},{"key":"10","unstructured":"10) Tsuboi, H., et al.: Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies. <i>Modern rheumatology\/the Japan Rheumatism Association<\/i>. <b>26<\/b>: 569-575, 2016."},{"key":"11","unstructured":"11) \u5bae\u91ce\u3000\u7ae0\uff0c\u4ed6\uff1a\u9175\u7d20\u514d\u75ab\u6e2c\u5b9a\u6cd5\u306b\u3088\u308b\u6297SS-A\/B\u6297\u4f53\u6a19\u6e96\u5316\u306e\u691c\u8a0e\uff0e\u81e8\u5e8a\u30ea\u30a6\u30de\u30c1\uff0e<b>24<\/b>: 247-259, 2012."},{"key":"12","unstructured":"12) Anami, A., et al.: The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block. <i>Modern rheumatology\/the Japan Rheumatism Association<\/i>. <b>23<\/b>: 653-658, 2013."},{"key":"13","unstructured":"13) Friedman, D.M., et al.: Utility of cardiac monitoring in fetuses at risk for congenital heart block: The PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. <i>Circulation<\/i>. <b>117<\/b>: 485-493, 2008."},{"key":"14","unstructured":"14) Jaeggi, E., et al.: The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. <i>Journal of the American College of Cardiology<\/i>. <b>55<\/b>: 2778-2784, 2010."},{"key":"15","unstructured":"15) Clancy, R.M., et al.: Maternal antibody responses to the 52-kd SSA\/RO p200 peptide and the development of fetal conduction defects. <i>Arthritis and rheumatism<\/i>. <b>52<\/b>: 3079-3086, 2005."},{"key":"16","unstructured":"16) Briassouli, P., et al.: A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies. <i>Rheumatology (Oxford, England)<\/i>. <b>52<\/b>: 1448-1453, 2013."},{"key":"17","unstructured":"17) Alvarez, D., et al.: A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block. <i>The Journal of biological chemistry<\/i>. <b>286<\/b>: 30444-30454, 2011."},{"key":"18","unstructured":"18) Clancy, R.M., et al.: Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. <i>Journal of immunology (Baltimore, Md: 1950)<\/i>. <b>184<\/b>: 2148-2155, 2010."},{"key":"19","unstructured":"19) Buyon, J.P., et al.: Cardiac manifestations of neonatal lupus erythematosus: Guidelines to management, integrating clues from the bench and bedside. <i>Nature clinical practice Rheumatology<\/i>. <b>5<\/b>: 139-148, 2009."},{"key":"20","unstructured":"20) Clancy, R.M., et al.: Endosomal Toll-like receptors in clinically overt and silent autoimmunity. <i>Immunological reviews<\/i>. <b>269<\/b>: 76-84, 2016."},{"key":"21","unstructured":"21) Izmirly, P.M., et al.: Neonatal lupus: Advances in understanding pathogenesis and identifying treatments of cardiac disease. <i>Current opinion in rheumatology<\/i>. <b>24<\/b>: 466-472, 2012."},{"key":"22","unstructured":"22) \u5f8c\u85e4\u7f8e\u8cc0\u5b50\uff1a\u65b0\u751f\u5150\u30eb\u30fc\u30d7\u30b9\uff0e\u5c0f\u5150\u5185\u79d1\uff0e47\u5dfb\u5897\u520a\u53f7:  919-922, 2015."},{"key":"23","unstructured":"23) Stevens, A.M., et al.: Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. <i>Lancet<\/i>. <b>362<\/b>: 1617-1623, 2003."},{"key":"24","unstructured":"24) \u5ca9\u672c\u96c5\u5f18\uff1a\u65b0\u751f\u5150\u30eb\u30fc\u30d7\u30b9\uff0e\u65e5\u672c\u81e8\u5e8a\u514d\u75ab\u5b66\u4f1a\u96d1\u8a8c\uff0e<b>28<\/b>: 4-9, 2005."},{"key":"25","unstructured":"25) Clancy, R.M., et al.: Cytokine polymorphisms and histologic expression in autopsy studies: Contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. <i>Journal of immunology (Baltimore, Md: 1950)<\/i>. <b>171<\/b>: 3253-3261, 2003."},{"key":"26","unstructured":"26) Clancy, R.M., et al.: Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. <i>Arthritis and rheumatism<\/i>. <b>62<\/b>: 3415-3424, 2010."},{"key":"27","unstructured":"27) Meisgen, S., et al.: The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence. <i>Journal of internal medicine<\/i>. <b>275<\/b>: 640-651, 2014."},{"key":"28","unstructured":"28) Friedman, D.M., et al.: Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. <i>The American journal of cardiology<\/i>. <b>103<\/b>: 1102-1106, 2009."},{"key":"29","unstructured":"29) Izmirly, P.M., et al.: Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system. <i>Annals of the rheumatic diseases<\/i>. <b>75<\/b>: 1161-1165, 2016."},{"key":"30","unstructured":"30) Friedman, D.M., et al.: Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. <i>Arthritis and rheumatism<\/i>. <b>62<\/b>: 1138-1146, 2010."},{"key":"31","unstructured":"31) Pisoni, C.N., et al.: Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. <i>Arthritis and rheumatism<\/i>. <b>62<\/b>: 1147-1152, 2010."},{"key":"32","unstructured":"32) Yokogawa, N., et al.: Effects of hydroxychloroquine on cutaneous lupus erythematosus: A multi-center double-blind randomized parallel-group trial. <i>Arthritis Rheumatol<\/i>. <b>69<\/b>: 791-799, 2017."},{"key":"33","unstructured":"33) Gotestam Skorpen, C., et al.: The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. <i>Annals of the rheumatic diseases<\/i>. <b>75<\/b>: 795-810, 2016."},{"key":"34","unstructured":"34) \u53e4\u5ddd\u798f\u5b9f\uff0c\u4ed6\uff1a\u30d2\u30c9\u30ed\u30ad\u30b7\u30af\u30ed\u30ed\u30ad\u30f3\u9069\u6b63\u4f7f\u7528\u306e\u624b\u5f15\u304d\uff0e\u65e5\u533b\u4f1a\u8a8c\uff0e<b>125<\/b>: 2049-2060, 2015."},{"key":"35","unstructured":"35) Izmirly, P.M., et al.: Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. <i>Annals of the rheumatic diseases<\/i>. <b>69<\/b>: 1827-1830, 2010."},{"key":"36","unstructured":"36) Izmirly, P.M., et al.: Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus. <i>Circulation<\/i>. <b>124<\/b>: 1927-1935, 2011."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u65b0\u751f\u5150\u30eb\u30fc\u30d7\u30b9"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/40\/2\/40_124\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T03:57:03Z","timestamp":1497671823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/40\/2\/40_124\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.40.124","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}